10:00 AM — 2:00 PM
Short Course: Aggregate Safety Assessment Planning9:00 AM — 5:00 PM
Short Course: Pharmacovigilance and Risk Management Planning7:00 AM — 5:35 PM
7:00 AM — 8:00 AM
8:00 AM — 8:15 AM
9:05 AM — 10:20 AM
Session 1: Global Safety Regulatory Updates: Japan and China Regions10:20 AM — 10:50 AM
Exhibitor Sponsored Session/Non-CE: Case Study hosted by PharSafer10:20 AM — 10:50 AM
10:50 AM — 11:50 AM
Session 2: Europe and United Kingdom Safety Regulatory Updates11:50 AM — 1:00 PM
1:00 PM — 2:30 PM
Session 3: FDA Safety Regulatory Updates2:30 PM — 3:15 PM
3:15 PM — 4:15 PM
Session 4: FDA Technical Specification for Implementing E2B R35:35 PM — 6:35 PM
7:00 AM — 4:35 PM
7:00 AM — 8:00 AM
8:00 AM — 8:25 AM
Welcome to Day 2 and DIA PV Community Update8:30 AM — 9:45 AM
Session 6: Signal Detection10:50 AM — 11:20 AM
Exhibitor Event/Non-CE: Case Study hosted by IQVIA10:50 AM — 11:20 AM
11:20 AM — 12:35 PM
Session 8: Artificial Intelligence and Machine Learning Use in Patient Safety12:35 PM — 1:35 PM
1:35 PM — 2:50 PM
Session 9: Real-World Evidence Support of Clinical Development Programs2:50 PM — 3:20 PM
3:20 PM — 4:35 PM
Session 10: Epidemiology in Post-Approval7:00 AM — 12:00 PM
7:00 AM — 8:00 AM
11:00 AM — 11:30 AM
11:30 AM — 12:45 PM
Panel Discussion: Safety Practices in Small Pharmaceutical Company Settings12:45 PM — 12:55 PM